These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


537 related items for PubMed ID: 25102039

  • 1. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P, Roeland E, Atayee R.
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [Abstract] [Full Text] [Related]

  • 2. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC, Davies D, Desai S, Malherbe S.
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [Abstract] [Full Text] [Related]

  • 3. Continuous intravenous infusion of ketamine and lidocaine as adjuvant analgesics in a 5-year-old patient with neuropathic cancer pain.
    Kajiume T, Sera Y, Nakanuno R, Ogura T, Karakawa S, Kobayakawa M, Taguchi S, Oshita K, Kawaguchi H, Sato T, Kobayashi M.
    J Palliat Med; 2012 Jun; 15(6):719-22. PubMed ID: 22401313
    [Abstract] [Full Text] [Related]

  • 4. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.
    Elsewaisy O, Slon B, Monagle J.
    Pain Med; 2010 Jun; 11(6):946-50. PubMed ID: 20624244
    [Abstract] [Full Text] [Related]

  • 5. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
    Grande LA, O'Donnell BR, Fitzgibbon DR, Terman GW.
    Anesth Analg; 2008 Oct; 107(4):1380-3. PubMed ID: 18806055
    [Abstract] [Full Text] [Related]

  • 6. Successful Treatment of Opioid-Refractory Cancer Pain with Short-Course, Low-Dose Ketamine.
    Waldfogel JM, Nesbit S, Cohen SP, Dy SM.
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):294-297. PubMed ID: 27754734
    [Abstract] [Full Text] [Related]

  • 7. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
    Okamoto Y, Tsuneto S, Tanimukai H, Matsuda Y, Ohno Y, Tsugane M, Uejima E.
    Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
    [Abstract] [Full Text] [Related]

  • 8. The use of ketamine in severe cases of refractory pain syndromes in the palliative care setting: a case series.
    Kerr C, Holahan T, Milch R.
    J Palliat Med; 2011 Sep; 14(9):1074-7. PubMed ID: 21838517
    [Abstract] [Full Text] [Related]

  • 9. Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature.
    Uprety D, Baber A, Foy M.
    Ann Hematol; 2014 May; 93(5):769-71. PubMed ID: 24232306
    [Abstract] [Full Text] [Related]

  • 10. Use of continuous intravenous ketamine for end-stage cancer pain in children.
    Conway M, White N, Jean CS, Zempsky WT, Steven K.
    J Pediatr Oncol Nurs; 2009 May; 26(2):100-6. PubMed ID: 19202116
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Parenteral administration of low dose ketamine for the treatment of neuropathic pain in cancer patients].
    Kong PE, Snijdelaar DG, Crul BJ.
    Ned Tijdschr Geneeskd; 2002 Dec 28; 146(52):2556-8. PubMed ID: 12532671
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trial.
    Rakhman E, Shmain D, White I, Ekstein MP, Kollender Y, Chazan S, Dadia S, Bickels J, Amar E, Weinbroum AA.
    Clin Ther; 2011 Jul 28; 33(7):863-73. PubMed ID: 21722959
    [Abstract] [Full Text] [Related]

  • 16. Case Report: Utility of Ketamine, Lidocaine, and Mexiletine as Nonopioid Adjuvants in Complex Cancer-Associated Pain.
    Hakim RC, Edmonds KP, Atayee RS.
    J Pain Palliat Care Pharmacother; 2018 Mar 28; 32(1):15-19. PubMed ID: 29737933
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.